CMP Therapeutics Pursues OTC Cold Indication For Chitin Nasal Spray
This article was originally published in The Pink Sheet Daily
Executive Summary
CMP also is looking at chitin in nutritional products and allergy and asthma therapies, and projects its nasal spray will generate annual global sales of $200 million.